In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...
Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.
“It’s not an easy life, but it is challenging and rewarding to be a part of this industry.” Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 ...
Umoja, founded in 2019, is developing in-body treatments to boost the effectiveness of immune cell therapies, targeting both ...